Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 494

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 494
---
 Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met: •the issuer of the securities that was formerly a shell company has ceased to be a shell company; •the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; •the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8 -Kreports; and •at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. We anticipate that following the consummation of the Business Combination, New Profusa will no longer be a shell company, and as a result, once the conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of the above noted restricted securities. As a result, it is anticipated that the Sponsor will be able to sell its common stock and warrants, and any shares of New Profusa Common Stock received as a result thereof, as applicable, pursuant to Rule 144 without registration one year after we have completed our initial business combination. 291

MANAGEMENT OF NEW PROFUSA AFTER THE BUSINESS COMBINATION References in this section to “we”, “our”, “us” and the “Company” generally refer to Profusa, prior to the Business Combination and New Profusa and its consolidated subsidiaries after giving effect to the Business Combination. Management and Board of Directors The following table sets forth the persons NorthView and Profusa anticipate will become the directors and executive officers of New Profusa.

| Name                              |     | Age |     | Position                                       |
| Directors and Executive Officers: |     |     |     |                                                |
| Ben C. Hwang, Ph.D.               |     |  57 |     | Chairman of the Board; Chief Executive Officer |
| Fred Knechtel                     |     |  64 |     | Chief Financial Officer                        |
| Rajesh Asorpota                   |     |  56 |     | Director